Iambic Therapeutics Files Form S-1 for Nasdaq IPO Under IAM
Iambic Therapeutics filed a Form S-1 with the SEC to list on Nasdaq under IAM, backed by Nvidia and Coatue, with $207.9M in cash and clinical HER2 data.
nasdaq ipo
Quantinuum Files for Nasdaq IPO Under Ticker QNT
Honeywell-backed Quantinuum publicly filed its S-1 on May 8, 2026, targeting a Nasdaq listing under QNT with JPMorgan and Morgan Stanley leading the book.